Investing Ideas
/
Bulgarian Pharmaceuticals & Biotech Potentially Undervalued Companies

Header cover image

Bulgarian Pharmaceuticals & Biotech Potentially Undervalued Companies

UPDATED Apr 24, 2024

Companies with a Value score of at least 3, ordered by Value score

14 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	21P Aurora Cannabis	CA$6.77	21.5%	n/a	CA$533.9m	CA$6.69	PE1.3x	E-52.1%	n/a
	BAYN Bayer	€26.73	0%	-55.8%	€26.5b	€36.21	PB0.8x	E46.3%	0.4%
	TEV Teva Pharmaceutical Industries	US$9.38	0%	11.7%	US$11.0b	US$10.55	PB1.6x	E64.8%	0%
	SNW Sanofi	€87.98	0%	-13.8%	€109.5b	€106.70	PE20.5x	E13.6%	4.2%
	AM1 Amgen	US$255.20	2.6%	18.6%	US$146.4b	US$280.68	PE21.8x	E8.9%	3.3%
	0QF Moderna	US$72.28	0%	n/a	US$36.3b	US$101.39	PS5.3x	E58.6%	n/a
	NVV1 Novavax	US$3.74	0%	n/a	US$580.8m	US$13.89	PE-1.1x	E88.2%	n/a
	EVT Evotec	€9.60	n/a	n/a	€1.7b	€25.28	PS2.2x	E55.2%	n/a
	6MK Merck	US$89.50	0%	n/a	US$218.2b	US$103.93	PE13.1x	E10.2%	3.2%
	JNJ Johnson & Johnson	US$158.90	0%	n/a	US$365.2b	US$184.50	PE26.1x	E11.8%	3.1%
	22UA BioNTech	US$121.65	0%	-18.3%	US$34.8b	US$182.54	PE3.1x	E-38.6%	n/a
	MRK Merck KGaA	€154.20	0%	-7.1%	€72.0b	€181.91	PE23.4x	E11.4%	1.3%
	4AB AbbVie	US$128.20	0%	n/a	US$255.5b	US$147.69	PE29.6x	E11.3%	4.1%
	2HQ Tilray Brands	US$1.67	n/a	n/a	US$1.4b	US$2.15	PS1.9x	E86.1%	n/a

Page 1 of 1